|Table of Contents|

Recent curative effect of X-knife with TACE on the primary liver cancer

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2017 02
Page:
237-240
Research Field:
Publishing date:

Info

Title:
Recent curative effect of X-knife with TACE on the primary liver cancer
Author(s):
Di Jie; Wang Qiang; Qi Fei
Oncology Department，Laiwu Central Hospital,Xinwen Mining Group,Shandong Laiwu 271103，China.
Keywords:
primary liver cancer; X-knife; conventional TACE; curative effect; safety
PACS:
R735.7
DOI:
10.3969/j.issn.1672-4992.2017.02.020
Abstract:
Objective:To analyze the clinical efficacy of conventional TACE combined with stereotactic body X knife treatment on liver cancer.Methods:Retrospectively analyze data of 96 primary liver cancer patients who were randomly divided into three groups,X-knife group,TACE group,X-knife combined with TACE group,32 cases in each.Observation indicators mainly include objective effect,AFP,ALT,AST,kidney (BUN,Cr),side effects,and survival.Results:General date of three groups of patients,including gender,HBSAg (+),and the Child-pugh score (A/B) were compared,the difference had no statistical significance (P＞0.05).After 4 week's treatment,curative effects were compared among three groups.The difference between X - knife group and conventional TACE alone group was not statistically significant (incidences of efficiency:28.13% vs 21.88%，P＞0.05).Joint group had better curative effects than conventional TACE group,with statistical differences between two groups(incidences of efficiency:46.88% vs 21.88%，P＜0.05).The survival time of joint group,simple X- knife,TACE alone group were (13.2±2.6) months,(8.8±2.2) months,(5.8±2.1) months.Survival time of joint group was prolonged compared with X-knife group and conventional TACE alone group,the difference was statistically significant.Joint group had a high score of KPS after treatment.Liver and kidney function of all the three groups were improved than before the treatment (P＜0.05).There was no significant difference (P＞0.05) among the liver and kidney function of three groups after the treatment.Conclusion:Combined with conventional X-knife treatment of primary liver cancer treatment has obvious curative effect,more effective than conventional TACE group.Combined with conventional X-knife treatment for primary liver cancer than conventional treatment group and X-knife can improve the patient's quality of life,prolong patient survival.

References:

［1］Tang ZY.Personal opinion on improving the outcome of theatment for liver cancer［J］.Chin J Hapatobiliary Surg,2010,16(8):561-562.［汤钊猷.提高肝癌疗效的我见［J］.中华肝胆外科杂志，2010,16(8):561-562.］
[2]Liu Hedai,Ding Gang,Zhang Ming,et al.Efficacy combined transcatheter arterial chemoembolization (TACE) and radiotherapy for advanced primary liver cancer［J］.Modern Oncology,2015,23(9):1258-1261.［刘合代，丁罡，张明，等.肝动脉栓塞化疗联合放疗治疗原发性肝癌的疗效分析［J］.现代肿瘤医学,2015,23(5):1258-1261.］
[3]Liu Jie,Liu Hongzhang,Zhou Ronglin,et al.Application of TACE combined with PSE in the treatment of primary liver cancer and hypersplenism［J］.Modern Oncology,2015,23(8):1097-1099.［刘杰，刘鸿章，周荣林，等.TACE联合PSE在原发性肝癌并脾亢治疗中的应用［J］.现代肿瘤医学,2015,23(8):1097-1099.］
[4] Zeng ZC,Jiang GL,Wang GM,et al.DNA-PKcs subunits in radiosensitization by hyperthermia on hepatocellular carcinoma hepG2 cell line［J］.World J Gastroenterol,2002,8(5):797-803.
[5] Goyal K,Einstein D,Yao M,et al.Cyberknife stereotactic body radiation therapy for nonresectable tumors of the liver:Preliminary results［J］.Cancer,2010,5:24.
[6] Honda Y,Kimura T,Aikata H,et al.Pilot study of stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma［J］.Hepatogastroenterology，2014,61(129):31-36.
[7] Honda Y,Kimura T,Aikata H,et al.Stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma［J］.J Gastroenterol Hepatol， 2013,28(3):530-536.
[8] Meza-Junco J,Montano-Loza AJ,Liu DM,et al.Locoregional radiological treatment for hepatocellular carcinoma.Which,when and how［J］?Cancer Treat Rev,2012,38(1):54-62.
[9] Kang JK,Kim MS,Cho CK,et al.Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization［L］.Cancer,2012,118(21):5424-5431.
[10] Higuchi T,Kikuchi M,Okazaki M,et al.Hepatocellular carcinoma after transcatheter hepatic arterial embolization.A histopathologic study of 84 resected cases［J］Cancer，1994,73(9):2259-2267.
[11]Choi C,Koom WS,Kim TH,et al.A prospective phase 2 multicenter study for the efficacy of radiation therapy following incomplete transarterial chemoembolization in unresectable hepatocellular carcinoma［J］.Int J Radiat Oncol Biol Phys,2014,90(5):1051-1060.
[12] Zhang LJ,Peng Q,Lu DH,et al.Three-dimensional conformal radiation therapy combined with transcatheter arterial chemoembolization for treatment of patients with hepatocellular carcinoma with portal vein tumor thrombus:A Meta-anylysis［J］.J Prac Hapatol,2015,18（3）：254-257.［张立洁,彭泉，芦东徽，等.三维适形放疗联合TACE治疗肝癌并发门静脉癌栓疗效的Meta分析［J］.实用肝脏病杂志，2015,18（3）：254-257.］

Memo

Memo:
-
Last Update: 2016-12-01